{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:16:37Z","timestamp":1791353797657,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejvs.2020.11.050","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T01:45:47Z","timestamp":1609379147000},"page":"484-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Comparing Safety and Efficacy of Rivaroxaban with Warfarin for Patients after Successful Stent Placement for Chronic Iliofemoral Occlusion: A Retrospective Single Institution Study"],"prefix":"10.1016","volume":"61","author":[{"given":"Xing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyou","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichuang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2020.11.050_bib1","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2020.11.050_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"Enden","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2020.11.050_bib3","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/j.1538-7836.2011.04516.x","article-title":"Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation","volume":"9","author":"Guanella","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ejvs.2020.11.050_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002772","article-title":"Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-Analysis","volume":"8","author":"Razavi","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.11.050_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jvir.2014.02.031","article-title":"Technical details and clinical outcomes of transpopliteal venous stent placement for postthrombotic chronic total occlusion of the iliofemoral vein","volume":"25","author":"Ye","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ejvs.2020.11.050_bib6","first-page":"889","article-title":"CIRSE standards of practice guidelines on iliocaval stenting","volume":"37","author":"Mahnken","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2020.11.050_bib7","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejvs.2020.11.050_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/ATVBAHA.115.303397","article-title":"Overview of the new oral anticoagulants: opportunities and challenges","volume":"35","author":"Yeh","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2020.11.050_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2020.11.050_bib10","first-page":"CD010956","article-title":"Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis","volume":"6","author":"Robertson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2020.11.050_bib11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2012.02.008","article-title":"New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper","volume":"59","author":"De Caterina","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2020.11.050_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ejvs.2020.11.050_bib13","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7 Suppl","key":"10.1016\/j.ejvs.2020.11.050_bib14","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.1016\/j.jvir.2009.04.034","article-title":"Reporting standards for endovascular treatment of lower extremity deep vein thrombosis","volume":"20","author":"Vedantham","year":"2009","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.ejvs.2020.11.050_bib15","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2020.11.050_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1538-7836.2009.03294.x","article-title":"Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization","volume":"7","author":"Kahn","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ejvs.2020.11.050_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jvs.2009.08.032","article-title":"Unexpected major role for venous stenting in deep reflux disease","volume":"51","author":"Raju","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2020.11.050_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejvs.2017.06.019","article-title":"Deep venous procedures performed in the national health service in England between 2005 and 2015","volume":"54","author":"Lim","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.11.050_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejvs.2015.02.007","article-title":"Editor\u2019s Choice \u2013 Management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS)","volume":"49","author":"Wittens","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.11.050_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejvs.2018.01.007","article-title":"Antithrombotic therapy following venous stenting: International Delphi Consensus","volume":"55","author":"Kristijonas","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.11.050_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.amjmed.2018.01.041","article-title":"Rivaroxaban versus warfarin and risk of post-thrombotic syndrome among patients with venous thromboembolism","volume":"131","author":"S\u00f8gaard","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.ejvs.2020.11.050_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.thromres.2018.01.013","article-title":"Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome","volume":"163","author":"Utne","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2020.11.050_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1076029618758955","article-title":"Postthrombotic syndrome in patients treated with rivaroxaban or warfarin for venous thromboembolism","volume":"24","author":"Coleman","year":"2018","journal-title":"Clin Appl Thromb-Hem"},{"key":"10.1016\/j.ejvs.2020.11.050_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1160\/TH16-01-0041","article-title":"Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin\/vitamin K antagonists for acute deep-vein thrombosis","volume":"116","author":"Cheung","year":"2016","journal-title":"Thrombo Haemostasis"},{"key":"10.1016\/j.ejvs.2020.11.050_bib25","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(17)30054-6","article-title":"Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study","volume":"4","author":"Larsen","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ejvs.2020.11.050_bib26","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1160\/TH17-03-0210","article-title":"Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism","volume":"117","author":"Coleman","year":"2017","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.ejvs.2020.11.050_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/acem.12713","article-title":"Cost of treating venous thromboembolism with heparin and warfarin versus home treatment with rivaroxaban","volume":"22","author":"Kahler","year":"2015","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ejvs.2020.11.050_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2018.10.027","article-title":"Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis","volume":"172","author":"Sebastian","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2020.11.050_bib29","first-page":"753","article-title":"Efficacy of rivaroxaban in preventing thrombosis after iliac vein stenting","volume":"38","author":"Suo","year":"2019","journal-title":"Herald Med"},{"key":"10.1016\/j.ejvs.2020.11.050_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0268355513491724","article-title":"Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May-Thurner syndrome","volume":"29","author":"Park","year":"2014","journal-title":"Phlebology"},{"key":"10.1016\/j.ejvs.2020.11.050_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0268355515596289","article-title":"Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstruction","volume":"31","author":"Langwieser","year":"2016","journal-title":"Phlebology"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588420310741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588420310741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:56:15Z","timestamp":1761047775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588420310741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1078588420310741"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2020.11.050","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing Safety and Efficacy of Rivaroxaban with Warfarin for Patients after Successful Stent Placement for Chronic Iliofemoral Occlusion: A Retrospective Single Institution Study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2020.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society for Vascular Surgery. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}